|Wright Medical Group, Inc. Announces Initial Release of the VALOR(TM) Ankle Fusion Nail System|
New Foot & Ankle Product Solidifies Wright’s Market-Leadership in Products for Surgical Treatment of Hindfoot Arthritis
Designed by world-renowned foot and ankle surgeons, the VALOR™ Ankle Fusion Nail system is a comprehensive and advanced solution for fusion of three bones in the foot and ankle: the calcaneus, the talus and the tibia. The VALOR™ Ankle Fusion Nail system consists of multiple implant sizes, lengths and configurations which ensures an accurate fit based on patients’ needs. Each fusion nail implant incorporates an innovative compression device which allows surgeons to control the compression between the bone surfaces. This enhanced compression feature is designed to maximize the likelihood of a solid fusion, thereby alleviating pain.
“Ankle arthritis is a growing problem, with two million people visiting
the doctor every year because of pain from ankle arthritis or
“The VALOR™ Ankle Fusion Nail is the next generation of fixation
technology that incorporates accurate instrumentation for
intra-operative reproducibility. Coupled with the INBONE™ total ankle
replacement, Wright uniquely offers a comprehensive portfolio of
products to address the challenges associated with complex ankle
The new VALOR™ Ankle Fusion Nail will be made available in a limited-release immediately in the U.S. through Wright’s specialized foot and ankle sales force. Full rollout is expected to be completed by the second quarter of 2010. Additionally, the system will be marketed in select countries outside the U.S. through Wright’s direct and distributor-based sales representatives.
The VALOR™ Ankle Fusion Nail is the latest addition to Wright’s market-leading suite of products for foot and ankle surgeons. These include the CHARLOTTE™ family of reconstructive implants, DARCO® locked plating systems, ORTHOLOC™ polyaxial locking systems, the BIOARCH® subtalar implant, SIDE-KICK® External Fixators, CANCELLO-PURE® and BIOFOAM™ osteotomy wedge systems, ENDO-FUSE™ intra-osseous implants, DART-FIRE™ small screw systems, GRAFTJACKET® regenerative tissue matrix, and the INBONE™ total ankle replacement.
This press release contains “forward-looking statements” as
defined under U.S. federal securities laws. These
statements reflect management’s current knowledge, assumptions, beliefs,
estimates, and expectations and express management’s current views of
future performance, results, and trends and may be identified by their
use of terms such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and
other similar terms. Forward-looking statements are
subject to a number of risks and uncertainties that could cause our
actual results to materially differ from those described in the
forward-looking statements. Such risks and uncertainties
include those discussed in our filings with the
Wright Medical Group, Inc.